Cargando…
ASK120067 potently suppresses B-cell or T-cell malignancies in vitro and in vivo by inhibiting BTK and ITK
Hyperactivation of Bruton’s tyrosine kinase (BTK) or interleukin-2-inducible T cell kinase (ITK) has been attributed to the pathogenesis of B-cell lymphoma or T-cell leukemia, respectively, which suggests that Bruton’s tyrosine kinase and interleukin-2-inducible T cell kinase are critical targets fo...
Autores principales: | Song, Peiran, Bai, Gang, Chan, Shingpan, Zhang, Tao, Tong, Linjiang, Su, Yi, Shen, Yanyan, Chen, Yi, Liu, Yingqiang, Lai, Mengzhen, Ning, Yi, Tang, Haotian, Fang, Yan, Ding, Ke, Ding, Jian, Xie, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9799096/ https://www.ncbi.nlm.nih.gov/pubmed/36588692 http://dx.doi.org/10.3389/fphar.2022.1071114 |
Ejemplares similares
-
Discovery of HCD3514 as a potent EGFR inhibitor against C797S mutation in vitro and in vivo
por: Lai, Mengzhen, et al.
Publicado: (2023) -
Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance
por: Zhang, Tao, et al.
Publicado: (2020) -
Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance
por: Zhang, Tao, et al.
Publicado: (2021) -
Correction: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance
por: Zhang, Tao, et al.
Publicado: (2023) -
Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in Mice
por: Schutt, Steven D., et al.
Publicado: (2015)